164 results
8-K
EX-99.1
VYNE
VYNE Therapeutics Inc.
13 Jan 25
Corporate Presentation January 2025
7:50am
. Finally, while VYNE believes its own internal research is reliable, such research has not been verified by any independent source. You are cautioned
8-K
EX-99.2
VYNE
VYNE Therapeutics Inc.
23 Dec 24
VYNE Therapeutics Reports Positive Top-line Phase 1a MAD Data for VYN202, its Novel BD2-Selective BET Inhibitor
7:42am
is reliable, such research has not been verified by any independent source . You are cautioned not to give undue weight to any such information
S-8
EX-23.1
VYNE
VYNE Therapeutics Inc.
19 Dec 24
Registration of securities for employees
4:27pm
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration
S-8
VYNE
VYNE Therapeutics Inc.
19 Dec 24
Registration of securities for employees
4:27pm
, independent registered public accounting firm.
23.2
Consent of Cooley LLP (included in Exhibit 5.1).
24.1
Powers of Attorney (included on signature
8-K
VYNE
VYNE Therapeutics Inc.
12 Dec 24
Departure of Directors or Certain Officers
4:01pm
of the selection by the audit committee of the board of directors of Baker Tilly US, LLP as the independent registered public accounting firm
S-8
cwz18c58 gj8y
1 Mar 24
Registration of securities for employees
5:15pm
S-8
EX-23.1
k8dovarpxrnrb2vif
1 Mar 24
Registration of securities for employees
5:15pm
S-8
EX-4.4
3f6xs25u
1 Mar 24
Registration of securities for employees
5:15pm
8-K
qll0uw9o4g1foi5109e9
3 Jan 24
VYNE Therapeutics Appoints Christine Borowski, Ph.D., to its Board of Directors
8:15am
S-8
EX-23.1
ey0j5opte2yzu tb
13 Dec 23
Registration of securities for employees
4:36pm
S-8
EX-23.2
zqrn3 7du7nemaojylq
13 Dec 23
Registration of securities for employees
4:36pm
S-8
kplez jgcxxn24dz
13 Dec 23
Registration of securities for employees
4:36pm